1 – 50 of 100
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Cumulative incidence of and risk factors for BCG infection after adjuvant BCG instillations
2024) In BJU International(
- Contribution to journal › Article
-
Mark
Initial surveillance in men with marker negative clinical stage IIA non-seminomatous germ cell tumours
2024) In BJU International(
- Contribution to journal › Article
-
Mark
A pilot study of an organised population‐based testing programme for prostate cancer
(
- Contribution to journal › Article
-
Mark
The psychosocial impact of prostate cancer screening for BRCA1 and BRCA2 carriers
(
- Contribution to journal › Article
- 2023
-
Mark
Validation of a prediction model for post-chemotherapy fibrosis in nonseminoma patients
(
- Contribution to journal › Article
- 2022
-
Mark
Complete metabolic response with [18F]fluorodeoxyglucose-positron emission tomography/computed tomography predicts survival following induction chemotherapy and radical cystectomy in clinically lymph node positive bladder cancer
(
- Contribution to journal › Article
-
Mark
Lymph swelling after radical prostatectomy and pelvic lymph node dissection
(
- Contribution to journal › Article
-
Mark
Increasing rates of urinary- and bloodstream infections following transrectal prostate biopsy in South Sweden
(
- Contribution to journal › Article
-
Mark
Incidence of penile intraepithelial neoplasia and treatment strategies in Sweden 2000–2019
(
- Contribution to journal › Article
-
Mark
Population-based randomized trial of screening for clinically significant prostate cancer ProScreen : a pilot study
(
- Contribution to journal › Article
- 2021
-
Mark
Should patients with low-risk renal cell carcinoma be followed differently after nephron-sparing surgery vs radical nephrectomy?
(
- Contribution to journal › Article
-
Mark
Prospective validation of microseminoprotein-β added to the 4Kscore in predicting high-grade prostate cancer in an international multicentre cohort
(
- Contribution to journal › Article
-
Mark
Surgeon heterogeneity significantly affects functional and oncological outcomes after radical prostatectomy in the Swedish LAPPRO trial
(
- Contribution to journal › Article
-
Mark
Penile intraepithelial neoplasia, penile cancer precursors and human papillomavirus prevalence in symptomatic preputium : a cross-sectional study of 351 circumcised men in Sweden
(
- Contribution to journal › Article
-
Mark
Personalised biopsy schedules based on risk of Gleason upgrading for patients with low-risk prostate cancer on active surveillance
(
- Contribution to journal › Article
- 2020
-
Mark
Prostate cancer cells enhance interleukin-15-mediated expansion of NK cells
(
- Contribution to journal › Article
-
Mark
Treatment and prognosis of patients with urinary bladder cancer with other primary cancers : a nationwide population-based study in the Bladder Cancer Data Base Sweden (BladderBaSe)
(
- Contribution to journal › Article
- 2019
-
Mark
Period-specific mean annual hospital volume of radical cystectomy is associated with outcome and perioperative quality of care : a nationwide population-based study
(
- Contribution to journal › Article
-
Mark
Oxidative stress and lower urinary tract symptoms : cause or consequence?
(
- Contribution to journal › Debate/Note/Editorial
- 2018
-
Mark
Familial risks in urolithiasis in the population of Sweden
(
- Contribution to journal › Article
-
Mark
The Movember Foundation's GAP3 cohort : a profile of the largest global prostate cancer active surveillance database to date
(
- Contribution to journal › Article
- 2017
-
Mark
Socioeconomic factors and penile cancer risk and mortality; a population-based study
(
- Contribution to journal › Article
-
Mark
Long-term third-party assessment of results after continent cutaneous diversion with Lundiana pouch
(
- Contribution to journal › Article
-
Mark
Sentinel node biopsy for prostate cancer : Report from a consensus panel meeting
(
- Contribution to journal › Article
- 2016
-
Mark
Oncologic and functional outcomes 1 year after radical prostatectomy for very low risk prostate cancer. Results from the prospective LAPPRO trial.
(
- Contribution to journal › Article
-
Mark
Interpretation of conventional survival analysis and competing risk analysis : An example of hypertension and prostate cancer
(
- Contribution to journal › Article
-
Mark
The Accuracy of Prostate Biopsies for Predicting Gleason Score in Radical Prostatectomy Specimens. Nationwide trends 2000-2012.
2016) In BJU International(
- Contribution to journal › Article
- 2015
-
Mark
Upper Limit of Cancer Extent on Biopsy Defining Very Low Risk Prostate Cancer.
(
- Contribution to journal › Article
-
Mark
Development of a standardised training curriculum for robotic surgery: a consensus statement from an international multidisciplinary group of experts
(
- Contribution to journal › Article
-
Mark
URB937, a peripherally-restricted inhibitor for fatty acid amide hydrolase, reduces prostaglandin E2 -induced bladder overactivity and hyperactivity of bladder mechano-afferent nerve fibers in rats.
2015) In BJU International(
- Contribution to journal › Article
- 2014
-
Mark
Is intermittent androgen-deprivation therapy beneficial for patients with advanced prostate cancer?
(
- Contribution to journal › Scientific review
- 2013
-
Mark
Can one blood draw replace transrectal ultrasonography-estimated prostate volume to predict prostate cancer risk?
(
- Contribution to journal › Article
-
Mark
Treatment with curative intent and survival in men with high-risk prostate cancer. A population-based study of 11 380 men with serum PSA level 20-100 ng/mL.
(
- Contribution to journal › Article
- 2012
-
Mark
Combined (18) F-fluorocholine and (18) F-fluoride positron emission tomography/computed tomography imaging for staging of high-risk prostate cancer.
(
- Contribution to journal › Article
-
Mark
Testosterone in prostate cancer: the Bethesda consensus.
(
- Contribution to journal › Article
- 2011
-
Mark
Cysteine-rich secretory protein 3 and β-microseminoprotein on prostate cancer needle biopsies do not have predictive value for subsequent prostatectomy outcome.
(
- Contribution to journal › Article
-
Mark
Intra-individual short-term variability of prostate-specific antigen and other kallikrein markers in a serial collection of blood from men under evaluation for prostate cancer.
(
- Contribution to journal › Article
-
Mark
The value of bladder mapping and prostatic urethra biopsies for detection of carcinoma in situ (CIS).
2011) In BJU International(
- Contribution to journal › Article
-
Mark
Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer : Preliminary analysis of the results of the IMPACT study
(
- Contribution to journal › Article
- 2010
-
Mark
The role of the transient receptor potential (TRP) superfamily of cation-selective channels in the management of the overactive bladder
(
- Contribution to journal › Scientific review
-
Mark
Efficacy of simplified bladder training in patients with overactive bladder receiving a solifenacin flexible-dose regimen: results from a randomized study
(
- Contribution to journal › Article
- 2009
-
Mark
Preserving bone health in patients with hormone-sensitive prostate cancer: the role of bisphosphonates
(
- Contribution to journal › Scientific review
-
Mark
Can dutasteride delay or prevent the progression of prostate cancer in patients with biochemical failure after radical therapy? Rationale and design of the Avodart after Radical Therapy for Prostate Cancer Study
(
- Contribution to journal › Article
-
Mark
Receptor-induced phasic activity of newborn mouse bladders is inhibited by protein kinase C and involves T-type Ca channels.
(
- Contribution to journal › Article
-
Mark
Treatment of prostate cancer with hormonal therapy in Europe
(
- Contribution to journal › Article
-
Mark
Integration of ERG gene mapping and gene-expression profiling identifies distinct categories of human prostate cancer
(
- Contribution to journal › Article
-
Mark
The developing role of hormonal therapy in the treatment of prostate cancer.
(
- Contribution to journal › Article
-
Mark
Signal transduction pathways of muscarinic receptor mediated activation in the newborn and adult mouse urinary bladder.
(
- Contribution to journal › Article
-
Mark
Vardenafil-induced relaxation and cyclic nucleotide levels in normal and obstructed rat urinary bladder.
(
- Contribution to journal › Article
-
Mark
Optimal management of metastatic renal cell carcinoma: an algorithm for treatment.
(
- Contribution to journal › Article